{"id":3613,"date":"2024-12-11T14:37:17","date_gmt":"2024-12-11T11:37:17","guid":{"rendered":"https:\/\/omegabio.com.tr\/?p=3613"},"modified":"2025-01-10T16:54:46","modified_gmt":"2025-01-10T13:54:46","slug":"ranibizumab-lucentis-elisa-kiti","status":"publish","type":"post","link":"https:\/\/omegabio.com.tr\/?p=3613","title":{"rendered":"Ranibizumab (Lucentis) ELISA Kiti"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"3613\" class=\"elementor elementor-3613\">\n\t\t\t\t\t\t<header data-particle_enable=\"false\" data-particle-mobile-disabled=\"false\" class=\"elementor-section elementor-top-section elementor-element elementor-element-dfa95f3 elementor-section-stretched elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"dfa95f3\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;,&quot;shape_divider_bottom&quot;:&quot;tilt&quot;,&quot;stretch_section&quot;:&quot;section-stretched&quot;}\">\n\t\t\t\t\t\t\t<div class=\"elementor-background-overlay\"><\/div>\n\t\t\t\t\t\t<div class=\"elementor-shape elementor-shape-bottom\" aria-hidden=\"true\" data-negative=\"false\">\n\t\t\t<svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 1000 100\" preserveAspectRatio=\"none\">\n\t<path class=\"elementor-shape-fill\" d=\"M0,6V0h1000v100L0,6z\"\/>\n<\/svg>\t\t<\/div>\n\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-wider\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-686a74d\" data-id=\"686a74d\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-eaeae6b elementor-invisible elementor-widget elementor-widget-heading\" data-id=\"eaeae6b\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;_animation&quot;:&quot;fadeIn&quot;}\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">Ranibizumab (Lucentis) ELISA Kit<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/header>\n\t\t\t\t<section data-particle_enable=\"false\" data-particle-mobile-disabled=\"false\" class=\"elementor-section elementor-top-section elementor-element elementor-element-25c4b8c elementor-section-stretched elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"25c4b8c\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;,&quot;stretch_section&quot;:&quot;section-stretched&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-6119f9d\" data-id=\"6119f9d\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<section data-particle_enable=\"false\" data-particle-mobile-disabled=\"false\" class=\"elementor-section elementor-inner-section elementor-element elementor-element-243f7cc animated-slow elementor-section-boxed elementor-section-height-default elementor-section-height-default elementor-invisible\" data-id=\"243f7cc\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;animation&quot;:&quot;fadeIn&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-inner-column elementor-element elementor-element-08f0929\" data-id=\"08f0929\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-b715cf3 elementor-widget elementor-widget-image\" data-id=\"b715cf3\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"682\" src=\"https:\/\/omegabio.com.tr\/wp-content\/uploads\/2024\/10\/adult-businesswoman-coffee-265036-1024x682.jpg\" class=\"attachment-large size-large wp-image-2525\" alt=\"\" srcset=\"https:\/\/omegabio.com.tr\/wp-content\/uploads\/2024\/10\/adult-businesswoman-coffee-265036-1024x682.jpg 1024w, https:\/\/omegabio.com.tr\/wp-content\/uploads\/2024\/10\/adult-businesswoman-coffee-265036-300x200.jpg 300w, https:\/\/omegabio.com.tr\/wp-content\/uploads\/2024\/10\/adult-businesswoman-coffee-265036-768x512.jpg 768w, https:\/\/omegabio.com.tr\/wp-content\/uploads\/2024\/10\/adult-businesswoman-coffee-265036.jpg 1280w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-1264255 elementor-widget elementor-widget-heading\" data-id=\"1264255\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">Call us Today<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-96f1186 elementor-widget elementor-widget-heading\" data-id=\"96f1186\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h4 class=\"elementor-heading-title elementor-size-default\">+(90) 312 920 14 50<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-04af0f0 elementor-widget elementor-widget-text-editor\" data-id=\"04af0f0\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Arp Kule \u0130\u015f Merkezi Fatih Sultan Mah. 2700. Cad. No: 3\/7 Etimesgut Ankara<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-1a8a7d1\" data-id=\"1a8a7d1\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-701e60d elementor-tabs-view-horizontal elementor-widget elementor-widget-tabs\" data-id=\"701e60d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"tabs.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-tabs\">\n\t\t\t<div class=\"elementor-tabs-wrapper\" role=\"tablist\" >\n\t\t\t\t\t\t\t\t\t<div id=\"elementor-tab-title-1171\" class=\"elementor-tab-title elementor-tab-desktop-title\" aria-selected=\"true\" data-tab=\"1\" role=\"tab\" tabindex=\"0\" aria-controls=\"elementor-tab-content-1171\" aria-expanded=\"false\">Product Description<\/div>\n\t\t\t\t\t\t\t\t\t<div id=\"elementor-tab-title-1172\" class=\"elementor-tab-title elementor-tab-desktop-title\" aria-selected=\"false\" data-tab=\"2\" role=\"tab\" tabindex=\"-1\" aria-controls=\"elementor-tab-content-1172\" aria-expanded=\"false\">Applications<\/div>\n\t\t\t\t\t\t\t\t\t<div id=\"elementor-tab-title-1173\" class=\"elementor-tab-title elementor-tab-desktop-title\" aria-selected=\"false\" data-tab=\"3\" role=\"tab\" tabindex=\"-1\" aria-controls=\"elementor-tab-content-1173\" aria-expanded=\"false\">Product Features<\/div>\n\t\t\t\t\t\t\t\t\t<div id=\"elementor-tab-title-1174\" class=\"elementor-tab-title elementor-tab-desktop-title\" aria-selected=\"false\" data-tab=\"4\" role=\"tab\" tabindex=\"-1\" aria-controls=\"elementor-tab-content-1174\" aria-expanded=\"false\">Technical Details<\/div>\n\t\t\t\t\t\t\t\t\t<div id=\"elementor-tab-title-1175\" class=\"elementor-tab-title elementor-tab-desktop-title\" aria-selected=\"false\" data-tab=\"5\" role=\"tab\" tabindex=\"-1\" aria-controls=\"elementor-tab-content-1175\" aria-expanded=\"false\">Catolog Number<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t<div class=\"elementor-tabs-content-wrapper\" role=\"tablist\" aria-orientation=\"vertical\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-tab-title elementor-tab-mobile-title\" aria-selected=\"true\" data-tab=\"1\" role=\"tab\" tabindex=\"0\" aria-controls=\"elementor-tab-content-1171\" aria-expanded=\"false\">Product Description<\/div>\n\t\t\t\t\t<div id=\"elementor-tab-content-1171\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"1\" role=\"tabpanel\" aria-labelledby=\"elementor-tab-title-1171\" tabindex=\"0\" hidden=\"false\"><p><strong>Ranibizumab (Lucentis) ELISA Kiti<\/strong>, serum veya plazma \u00f6rneklerinde Ranibizumab seviyelerinin do\u011fru ve g\u00fcvenilir bir \u015fekilde \u00f6l\u00e7\u00fclmesi i\u00e7in geli\u015ftirilmi\u015f ileri d\u00fczey bir ba\u011f\u0131\u015f\u0131kl\u0131k testi kitidir. Ranibizumab, ya\u015fa ba\u011fl\u0131 makula dejenerasyonu (AMD), diyabetik makula \u00f6demi (DME) ve retina damar t\u0131kan\u0131kl\u0131\u011f\u0131 (RVO) gibi \u00e7e\u015fitli retina hastal\u0131klar\u0131n\u0131n tedavisinde kullan\u0131lan monoklonal bir antikor olup, g\u00f6zde anormal kan damarlar\u0131n\u0131n b\u00fcy\u00fcmesinden sorumlu olan vask\u00fcler endotelyal b\u00fcy\u00fcme fakt\u00f6r\u00fcn\u00fc (VEGF) inhibe ederek etkili olur. Bu kit, tedavi g\u00f6ren hastalarda Ranibizumab seviyelerinin do\u011fru bir \u015fekilde izlenmesini sa\u011flayarak, klinik uzmanlar\u0131n terap\u00f6tik ila\u00e7 konsantrasyonlar\u0131n\u0131 optimal tedavi aral\u0131\u011f\u0131nda tutmalar\u0131na yard\u0131mc\u0131 olur.<\/p><p>Ranibizumab seviyelerinin do\u011fru bir \u015fekilde izlenmesi, tedavi etkinli\u011fini ve hastalar\u0131n tedaviye verdi\u011fi yan\u0131t\u0131 de\u011ferlendirmek i\u00e7in olduk\u00e7a \u00f6nemlidir. <strong>Ranibizumab (Lucentis) ELISA Kiti<\/strong>, ara\u015ft\u0131rmac\u0131lara ve klinik laboratuvarlara, hastalar\u0131n tedaviye nas\u0131l yan\u0131t verdi\u011fini de\u011ferlendirme ve dozaj ayarlamalar\u0131 yaparak tedavi faydalar\u0131n\u0131 maksimuma \u00e7\u0131karmak ve yan etkileri en aza indirmek i\u00e7in bir ara\u00e7 sunar. Ranibizumab&#8217;\u0131n kan dola\u015f\u0131m\u0131ndaki konsantrasyonunu \u00f6l\u00e7erek, klinik uzmanlar, ila\u00e7 seviyelerine dayanarak tedavi plan\u0131n\u0131 ayarlama konusunda bilin\u00e7li kararlar alabilir ve b\u00f6ylece hastalar\u0131n tedavi sonu\u00e7lar\u0131n\u0131 iyile\u015ftirebilirler.<\/p><p>Tedavi izleme s\u00fcrecinin yan\u0131 s\u0131ra, <strong>Ranibizumab ELISA Kiti<\/strong>, farmakokinetik \u00e7al\u0131\u015fmalarda da de\u011ferli bir ara\u00e7t\u0131r. \u0130la\u00e7\u0131n emilim, da\u011f\u0131l\u0131m, metabolizma ve at\u0131l\u0131m (ADME) s\u00fcre\u00e7lerine dair bilgiler sunar. Ranibizumab\u2019\u0131n v\u00fccutta nas\u0131l davrand\u0131\u011f\u0131n\u0131 anlamak, daha verimli dozaj rejimlerinin geli\u015ftirilmesine, tedavilerin bireysel hastalara g\u00f6re uyarlanmas\u0131na ve tedavi s\u00fcre\u00e7lerinin uzun vadeli etkilerinin de\u011ferlendirilmesine yard\u0131mc\u0131 olur. Bu bilgiler, klinik uygulamalar\u0131n geli\u015fmesine ve retina hastal\u0131klar\u0131 olan hastalar\u0131n y\u00f6netiminin optimize edilmesine katk\u0131 sa\u011flar.<\/p><\/div>\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-tab-title elementor-tab-mobile-title\" aria-selected=\"false\" data-tab=\"2\" role=\"tab\" tabindex=\"-1\" aria-controls=\"elementor-tab-content-1172\" aria-expanded=\"false\">Applications<\/div>\n\t\t\t\t\t<div id=\"elementor-tab-content-1172\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"2\" role=\"tabpanel\" aria-labelledby=\"elementor-tab-title-1172\" tabindex=\"0\" hidden=\"hidden\"><p><strong>Tedavi \u0130zleme:<\/strong><br \/><strong>Ranibizumab (Lucentis) ELISA Kiti<\/strong>, Ranibizumab tedavisi g\u00f6ren hastalarda tedavi izleme i\u00e7in olduk\u00e7a \u00f6nemlidir. Serum veya plazmadaki Ranibizumab konsantrasyonunu \u00f6l\u00e7erek, klinik uzmanlar ila\u00e7 seviyelerinin tedavi aral\u0131\u011f\u0131nda kald\u0131\u011f\u0131ndan emin olabilirler. \u0130la\u00e7 konsantrasyonlar\u0131n\u0131 izlemek, tedavinin etkinli\u011fini de\u011ferlendirmeye yard\u0131mc\u0131 olur ve sa\u011fl\u0131k profesyonellerinin dozajda gerekli ayarlamalar\u0131 yapmalar\u0131n\u0131 sa\u011flar. Bu, hastalar\u0131n retina hastal\u0131klar\u0131 i\u00e7in en iyi klinik sonu\u00e7lar\u0131 elde etmelerine yard\u0131mc\u0131 olur.<\/p><p><strong>Farmakokinetik \u00c7al\u0131\u015fmalar:<\/strong><br \/><strong>Ranibizumab (Lucentis) ELISA Kiti<\/strong>, farmakokinetik \u00e7al\u0131\u015fmalarda \u00f6nemli bir ara\u00e7t\u0131r ve ilac\u0131n v\u00fccutta nas\u0131l da\u011f\u0131ld\u0131\u011f\u0131, metabolize oldu\u011fu ve at\u0131ld\u0131\u011f\u0131 hakk\u0131nda kritik bilgiler sa\u011flar. Bu \u00e7al\u0131\u015fmalar, Ranibizumab\u2019\u0131n v\u00fccutta nas\u0131l davrand\u0131\u011f\u0131n\u0131 anlamak i\u00e7in \u00e7ok \u00f6nemlidir ve ara\u015ft\u0131rmac\u0131lar\u0131n ilac\u0131n v\u00fccutta nas\u0131l etki g\u00f6sterdi\u011fini ve etkilerinin nas\u0131l s\u00fcrd\u00fc\u011f\u00fcn\u00fc incelemelerine olanak tan\u0131r. Elde edilen veriler, dozaj rejimlerini optimize etmek i\u00e7in kullan\u0131labilir ve tedavilerin bireysel farmakokinetik profillere g\u00f6re uyarlanmas\u0131n\u0131 sa\u011flar.<\/p><p><strong>Yan Etki \u0130zleme:<\/strong><br \/><strong>Ranibizumab<\/strong> seviyelerinin do\u011fru bir \u015fekilde izlenmesi, y\u00fcksek veya d\u00fc\u015f\u00fck ila\u00e7 konsantrasyonlar\u0131na ba\u011fl\u0131 olas\u0131 yan etkilerin belirlenmesinde kritik rol oynar. <strong>Ranibizumab (Lucentis) ELISA Kiti<\/strong>, toksisite veya yetersiz terap\u00f6tik yan\u0131t\u0131 g\u00f6sterebilecek ila\u00e7 seviyelerinin etkin bir \u015fekilde tespit edilmesini sa\u011flar. \u0130la\u00e7 konsantrasyonlar\u0131n\u0131 izleyerek, sa\u011fl\u0131k profesyonelleri yan etkilerle kar\u015f\u0131la\u015fma riski ta\u015f\u0131yan hastalar\u0131 belirleyebilir ve hastan\u0131n sa\u011fl\u0131\u011f\u0131 \u00fczerinde olumsuz etkilerin en aza indirilmesi i\u00e7in h\u0131zl\u0131 bir \u015fekilde d\u00fczeltici \u00f6nlemler alabilir.<\/p><p><strong>Biyoyararlan\u0131m ve Biyoe\u015fde\u011ferlik \u00c7al\u0131\u015fmalar\u0131:<\/strong><br \/><strong>Ranibizumab (Lucentis) ELISA Kiti<\/strong>, Ranibizumab\u2019\u0131n farkl\u0131 form\u00fclasyonlar\u0131n\u0131n veya biyoe\u015fde\u011ferlerinin etkinli\u011fini ve g\u00fcvenli\u011fini ara\u015ft\u0131ran biyoyararlan\u0131m ve biyoe\u015fde\u011ferlik \u00e7al\u0131\u015fmalar\u0131 i\u00e7in de faydal\u0131d\u0131r. Bu testler, alternatif form\u00fclasyonlar\u0131n veya biyoe\u015fde\u011ferlerin orijinal ila\u00e7la ayn\u0131 terap\u00f6tik faydalar\u0131 sa\u011flad\u0131\u011f\u0131ndan emin olmak i\u00e7in \u00f6nemlidir. Ranibizumab\u2019\u0131n farkl\u0131 versiyonlar\u0131n\u0131n biyoyararlan\u0131m\u0131 kar\u015f\u0131la\u015ft\u0131r\u0131larak, g\u00fcvenlik ve etkinlik i\u00e7in gerekli standartlara uyduklar\u0131 do\u011frulanabilir ve b\u00f6ylece hastalar\u0131n y\u00fcksek kaliteli tedaviler almas\u0131 sa\u011flan\u0131r.<\/p><\/div>\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-tab-title elementor-tab-mobile-title\" aria-selected=\"false\" data-tab=\"3\" role=\"tab\" tabindex=\"-1\" aria-controls=\"elementor-tab-content-1173\" aria-expanded=\"false\">Product Features<\/div>\n\t\t\t\t\t<div id=\"elementor-tab-content-1173\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"3\" role=\"tabpanel\" aria-labelledby=\"elementor-tab-title-1173\" tabindex=\"0\" hidden=\"hidden\"><p><strong>Y\u00fcksek Hassasiyet:<\/strong><br \/><strong>Ranibizumab (Lucentis) ELISA Kiti<\/strong>, serum veya plazma \u00f6rneklerinde Ranibizumab\u2019\u0131n en k\u00fc\u00e7\u00fck miktarlar\u0131n\u0131 bile tespit edebilen y\u00fcksek hassasiyet sunar. Bu seviyedeki hassasiyet, etkili tedavi izlemesi i\u00e7in \u00e7ok \u00f6nemlidir \u00e7\u00fcnk\u00fc ila\u00e7 seviyelerinin do\u011fru bir \u015fekilde \u00f6l\u00e7\u00fclmesini sa\u011flar, hatta d\u00fc\u015f\u00fck konsantrasyonlarda bile. Bu, tedavi s\u0131ras\u0131nda do\u011fru dozaj\u0131n sa\u011flanabilmesi i\u00e7in kritik bir \u00f6zelliktir, \u00e7\u00fcnk\u00fc hem a\u015f\u0131r\u0131 tedaviden hem de eksik tedaviden ka\u00e7\u0131n\u0131lmas\u0131n\u0131 sa\u011flar. Bu kitin y\u00fcksek hassasiyeti, tedavi izlemesini g\u00fcvenilir k\u0131lar ve terap\u00f6tik sonu\u00e7lar\u0131n optimize edilmesine yard\u0131mc\u0131 olur.<\/p><p><strong>H\u0131zl\u0131 ve Kolay Uygulama:<\/strong><br \/><strong>Ranibizumab (Lucentis) ELISA Kiti<\/strong>, basitlik ve verimlilik g\u00f6z \u00f6n\u00fcnde bulundurularak tasarlanm\u0131\u015ft\u0131r. Protokol, izlenmesi kolay ad\u0131mlardan olu\u015fur ve laboratuvarlar\u0131n h\u0131zl\u0131 bir \u015fekilde sonu\u00e7 almas\u0131n\u0131 sa\u011flar. Kullan\u0131c\u0131 dostu tasar\u0131m, testin karma\u015f\u0131kl\u0131\u011f\u0131n\u0131 azalt\u0131r ve hem deneyimli ara\u015ft\u0131rmac\u0131lar hem de klinik personel i\u00e7in uygundur. Bu h\u0131zl\u0131 ve kolay uygulama, de\u011ferli zaman\u0131n tasarruf edilmesini sa\u011flar ve sa\u011fl\u0131k hizmeti sa\u011flay\u0131c\u0131lar\u0131n\u0131n Ranibizumab tedavisi g\u00f6ren hastalar\u0131n ila\u00e7 seviyelerini h\u0131zla de\u011ferlendirmelerine olanak tan\u0131r. Sonu\u00e7 olarak, klinik karar verme s\u00fcreci iyile\u015fir ve tedavi s\u00fcreci daha verimli hale gelir.<\/p><p><strong>Spesifiklik:<\/strong><br \/><strong>Ranibizumab (Lucentis) ELISA Kiti<\/strong>nin en \u00f6nemli \u00f6zelliklerinden biri y\u00fcksek spesifisitesidir. Kit, yaln\u0131zca Ranibizumab ile ba\u011flanan, y\u00fcksek \u00f6zg\u00fcll\u00fc\u011fe sahip antikorlar kullan\u0131r, bu da yanl\u0131\u015f pozitiflerin olas\u0131l\u0131\u011f\u0131n\u0131 minimize eder. Bu, sonu\u00e7lar\u0131n do\u011fru ve g\u00fcvenilir olmas\u0131n\u0131 sa\u011flar, \u00f6rnekte bulunan di\u011fer maddelerden etkilenmeden. Antikorlar\u0131n spesifisitesi, \u00e7apraz reaktivite riskini azalt\u0131r ve testi Ranibizumab seviyelerinin tespit edilmesi i\u00e7in son derece g\u00fcvenilir hale getirir. Bu do\u011fruluk, ila\u00e7 seviyelerinin do\u011fru bir \u015fekilde \u00f6l\u00e7\u00fclmesinin \u00e7ok \u00f6nemli oldu\u011fu klinik ortamlarda kritik bir rol oynar.<\/p><p><strong>Geni\u015f Dinamik Aral\u0131k:<\/strong><br \/><strong>Ranibizumab (Lucentis) ELISA Kiti<\/strong>, geni\u015f dinamik aral\u0131kta do\u011fru ve hassas sonu\u00e7lar sa\u011flamak \u00fczere tasarlanm\u0131\u015ft\u0131r. Ranibizumab\u2019\u0131n konsantrasyonu d\u00fc\u015f\u00fck veya y\u00fcksek olsun, kit g\u00fcvenilir \u00f6l\u00e7\u00fcmler sunabilir, bu da onu \u00e7e\u015fitli klinik ve ara\u015ft\u0131rma uygulamalar\u0131 i\u00e7in uygun hale getirir. Geni\u015f dinamik aral\u0131k, ila\u00e7 seviyeleri de\u011fi\u015fken olan hastalar\u0131n bile do\u011fru bir \u015fekilde izlenmesini sa\u011flar, bu da kitin \u00e7ok y\u00f6nl\u00fcl\u00fc\u011f\u00fcn\u00fc art\u0131r\u0131r. Geni\u015f bir konsantrasyon aral\u0131\u011f\u0131nda do\u011fru \u00f6l\u00e7\u00fcmler sa\u011flayabilme yetene\u011fi, tedavi y\u00f6netimi ve farmakokinetik \u00e7al\u0131\u015fmalar\u0131 i\u00e7in \u00f6nemlidir, b\u00f6ylece hi\u00e7bir hasta test s\u0131n\u0131rlar\u0131n\u0131n d\u0131\u015f\u0131na \u00e7\u0131kmaz.<\/p><\/div>\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-tab-title elementor-tab-mobile-title\" aria-selected=\"false\" data-tab=\"4\" role=\"tab\" tabindex=\"-1\" aria-controls=\"elementor-tab-content-1174\" aria-expanded=\"false\">Technical Details<\/div>\n\t\t\t\t\t<div id=\"elementor-tab-content-1174\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"4\" role=\"tabpanel\" aria-labelledby=\"elementor-tab-title-1174\" tabindex=\"0\" hidden=\"hidden\"><p>96 well plates are coated with VEGF to capture Ranibizumab from the sample, ensuring specific binding and accurate detection.<\/p><p>Sensitivity: 98.5%<\/p><p>Specificity: 99%<\/p><\/div>\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-tab-title elementor-tab-mobile-title\" aria-selected=\"false\" data-tab=\"5\" role=\"tab\" tabindex=\"-1\" aria-controls=\"elementor-tab-content-1175\" aria-expanded=\"false\">Catolog Number<\/div>\n\t\t\t\t\t<div id=\"elementor-tab-content-1175\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"5\" role=\"tabpanel\" aria-labelledby=\"elementor-tab-title-1175\" tabindex=\"0\" hidden=\"hidden\"><p>SC-RAN-001<\/p><\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Ranibizumab (Lucentis) ELISA Kit Call us Today +(90) 312 920 14 50 Arp Kule \u0130\u015f Merkezi Fatih Sultan Mah. 2700. [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"elementor_header_footer","format":"standard","meta":{"_eb_attr":"","_eb_data_table":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[406],"tags":[434],"class_list":["post-3613","post","type-post","status-publish","format-standard","hentry","category-therapeutic-mab-quantification-kits-tr","tag-elisa"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/omegabio.com.tr\/index.php?rest_route=\/wp\/v2\/posts\/3613","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/omegabio.com.tr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/omegabio.com.tr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/omegabio.com.tr\/index.php?rest_route=\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/omegabio.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3613"}],"version-history":[{"count":4,"href":"https:\/\/omegabio.com.tr\/index.php?rest_route=\/wp\/v2\/posts\/3613\/revisions"}],"predecessor-version":[{"id":3620,"href":"https:\/\/omegabio.com.tr\/index.php?rest_route=\/wp\/v2\/posts\/3613\/revisions\/3620"}],"wp:attachment":[{"href":"https:\/\/omegabio.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3613"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/omegabio.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3613"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/omegabio.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3613"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}